Other substances

IDX-184

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.	in silico			Feb/28/2020

AI-suggested references

Link	Publication date
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective	Jun/30/2020
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective	May/06/2020
Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic	Dec/04/2020
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study	Mar/25/2020
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19	Apr/23/2021